Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?
Novonesis is exploring whether gut health supplements could benefit patients taking GLP-1 weight-loss drugs, opening up a potentially lucrative new market.
Read at CNBC(opens in a new tab)
Full coverage
Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom? (opens CNBC in a new tab)
Novonesis is exploring whether gut health supplements could benefit patients taking GLP-1 weight-loss drugs, opening up a potentially lucrative new market.